• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.04% Nasdaq Up 0.26%

    Echo Therapeutics, Inc. (ECTE)

    -NasdaqCM
    1.20 Down 0.02(1.65%) 11:22AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:1.22
    Open:1.20
    Bid:1.17 x 100
    Ask:1.19 x 100
    1y Target Est:2.00
    Beta:2.41
    Next Earnings Date:N/A
    Day's Range:1.11 - 1.20
    52wk Range:0.39 - 4.13
    Volume:35,026
    Avg Vol (3m):119,314
    Market Cap:15.16M
    P/E (ttm):N/A
    EPS (ttm):-1.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ECTE

    Comparison

    Symbol% ChgMkt Cap
    ECTEDown 1.65%15.16M
    ABTUp 0.85%69.51B
    DXCMDown 0.28%4.34B
    MDTDown 0.54%73.07B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):893.32
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.19
    Quarterly EPS Est (Dec-14) :-0.32
    Mean Recommendation*:5.0
    PEG Ratio (5 yr expected):-0.03

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Echo Therapeutics, Inc. is engaged in the development of transdermal skin permeation and diagnostic medical devices. It is developing Symphony CGM system (Symphony), a needle-free wireless continuous glucose monitoring system for use in hospital c... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback